Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.


Atalar B. , Ozsahin M., Call J., Napieralska A., Kamer S., Villa S., ...More

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol.127, no.1, pp.96-102, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 127 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.1016/j.radonc.2017.12.028
  • Title of Journal : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • Page Numbers: pp.96-102

Abstract

Background and purpose: The optimal treatment for adults with newly diagnosed medulloblastoma (MB) has not been defined. We report a large series of cases from the Rare Cancer Network.